Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.1%

3 terminated/withdrawn out of 42 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

45%

19 trials in Phase 3/4

Results Transparency

0 of 24 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 1

15(35.7%)

Phase 3

15(35.7%)

Phase 2

6(14.3%)

Phase 4

4(9.5%)

Early Phase 1

1(2.4%)

N/A

1(2.4%)

42Total

Phase 1(15)

Phase 3(15)

Phase 2(6)

Phase 4(4)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (42)

Showing 20 of 42 trials

NCT06732583Phase 1Active Not Recruiting

A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years

Role: lead

NCT05935176Phase 4Active Not Recruiting

Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)

Role: lead

NCT07017777Phase 3Recruiting

A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)

Role: lead

NCT07203755Phase 1Recruiting

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Role: lead

NCT06857370Phase 3Active Not Recruiting

Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine

Role: lead

NCT06389513Phase 4Active Not Recruiting

Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants

Role: lead

NCT06700148Phase 3Active Not Recruiting

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year Olds

Role: lead

NCT06226714Phase 3Active Not Recruiting

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

Role: lead

NCT06621654Phase 1Active Not Recruiting

Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine

Role: lead

NCT06577298Phase 1Recruiting

A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers

Role: lead

NCT06011200Phase 3Completed

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

Role: lead

NCT05005156Phase 2Completed

Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Ad5-nCoV) in Adults 18 Years of Age and Older, Living With HIV

Role: collaborator

NCT05293223Phase 2Completed

Phase IIB Study of Recombinant Novel Coronavirus Vaccine

Role: collaborator

NCT06056050Phase 1Active Not Recruiting

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)

Role: lead

NCT06131554Phase 3Active Not Recruiting

A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years

Role: lead

NCT05951725Phase 3Active Not Recruiting

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)

Role: lead

NCT06708286Phase 2Active Not Recruiting

A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)

Role: lead

NCT06101173Phase 1Completed

A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

Role: lead

NCT05373485Phase 1Completed

Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

Role: lead

NCT05622942Phase 1Completed

Clinical Trial of Recombinant Pneumococcal Protein Vaccine

Role: lead